← FDA Drug Approvals (Drugs@FDA)

POSACONAZOLE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA · Approved 2024-07-18

Drug application

FDA Application #

ANDA217119

Application type

Abbreviated New Drug Application (Generic)

Brand name

POSACONAZOLE

Generic name

POSACONAZOLE

Active ingredients

POSACONAZOLE

Dosage form

TABLET, DELAYED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

AUROBINDO PHARMA

Manufacturer

Aurobindo Pharma Limited

First approval

2024-07-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown